Chantal Morel is a Research Officer within LSE Health. Her work is concentrated in the area of pharmaceutical policy, with focus on regulation and innovation. Her current projects explore the determinants of global pharmaceutical prices as well as intra- and extra-market-driven mechanisms to drive R&D in key areas of unmet medical need. Prior to joining the LSE Morel worked in health policy and economics as a Research Fellow at the London School of Hygiene & Tropical Medicine, as a Health Impact Assessment Adviser in a large INGO, and as a Health Economist within the guideline branch of the English national health authority.
For a full list of Chantal's publications, please see her LSE Research Online page